Gene · 6530
Papers3,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,539
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Persistent binding at dopamine transporters determines sustained psychostimulant effects. | Proc Natl Acad Sci U S A | 2023 | 36730201 | PubTator, text mining | PubMed |
| Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit/hyperactivity disorder. | Sci Rep | 2023 | 36717626 | PubTator, text mining | PubMed |
| Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments. | Sci Rep | 2023 | 36707691 | PubTator, text mining | PubMed |
| Explaining Accurate Predictions of Multitarget Compounds with Machine Learning Models Derived for Individual Targets. | Molecules | 2023 | 36677879 | PubTator, text mining | PubMed |
| Molecular Landscape of Tourette's Disorder. | Int J Mol Sci | 2023 | 36674940 | PubTator, text mining | PubMed |
| Altered Fractional Amplitude of Low-Frequency Fluctuation in Anxious Parkinson's Disease. | Brain Sci | 2023 | 36672068 | PubTator, text mining | PubMed |
| Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers. | Int J Neuropsychopharmacol | 2023 | 36655406 | PubTator, text mining | PubMed |
| Unravelling neurotransmitters impairment in primary progressive aphasias. | Hum Brain Mapp | 2023 | 36649260 | PubTator, text mining | PubMed |
Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion. | J Clin Neurol | 2023 | 36647224 | PubTator, text mining | PubMed |
| Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence. | Eur J Clin Pharmacol | 2023 | 36645468 | PubTator, text mining | PubMed |
| Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART. | Alzheimers Dement | 2023 | 36642985 | PubTator, text mining | PubMed |
| Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma. | Semin Nucl Med | 2023 | 36641337 | PubTator, text mining | PubMed |
| Pharmacogenetics of anxiety and depression in Alzheimer's disease. | Pharmacogenomics | 2023 | 36628952 | PubTator, text mining | PubMed |
| Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder. | Neuropharmacology | 2023 | 36623804 | PubTator, text mining | PubMed |
| Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review. | Int J Mol Sci | 2023 | 36614278 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Scombroid Food Poisoning. | Int J Mol Sci | 2023 | 36614252 | PubTator, text mining | PubMed |
| Noradrenergic therapies for apathy in Alzheimer's disease? | J Neurol Neurosurg Psychiatry | 2023 | 36600570 | PubTator, text mining | PubMed |
| Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-Principle. | Adv Sci (Weinh) | 2023 | 36596691 | PubTator, text mining | PubMed |
| State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer's disease: Challenges and opportunities. | Neurosci Biobehav Rev | 2023 | 36526031 | PubTator, text mining | PubMed |
| Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults. | J Psychopharmacol | 2023 | 36515395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6530/papers?page=19